NEW MJ NEWS

AbbVie to Present at the Bernstein 38th Annual Strategic Decisions Conference

AbbVie (NYSE: ABBV) will participate in the Bernstein 38th Annual Strategic Decisions Conference on Wednesday, June 1, 2022. Richard A. Gonzalez, chairman and chief executive officer, will present at 10:00 a.m. Central Time.

A live audio webcast of the presentation will be accessible through AbbVie’s Investor Relations website at investors.abbvie.com. An archived edition of the session will be available later that day.

About AbbVie
AbbVie’s mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people’s lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, women’s health and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on Twitter, Facebook, Instagram, YouTube and LinkedIn.

View original content:https://www.prnewswire.com/news-releases/abbvie-to-present-at-the-bernstein-38th-annual-strategic-decisions-conference-301554489.html

SOURCE AbbVie


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

 AgraFlora Organics International Inc. (AGRA) (AGFAF) Organics Reviews German Cannabis Industry

AgraFlora Organics Reviews German Cannabis Industry; Begins Immediate Cannabis Supply Integration into…

CLS Holdings USA Inc. (CLSH) Announces Key Addition to Its Management Team: Gregg Carlson Appointed CFO

CLS Holdings USA, Inc Announces Key Addition to Its Management Team: Gregg…

European Expansion of Cannvas MedTech Inc. (MTEC.CN) (CANVF) With Strong Focus on Intelligent Cannabis Education

European Expansion of Cannvas Continues With Strong Focus on Intelligent Cannabis Education…

Aurora Cannabis Inc. (ACBFF) completes $230 million convertible debenture offering

Aurora completes $230 million convertible debenture offering Aurora Cannabis Inc. (“Aurora“) (ACB.TO)…